Does High-Dose Prophylactic Acyclovir Add Benefit in Allogeneic Marrow Transplant Recipients Receiving Prophylactic or Preemptive Ganciclovir?

  • Boeckh, Michael
  • Gooley, Ted
  • Leisenring, Wendy
  • Myerson, David
  • Corey, Lawrence

  • Fred Hutchinson Cancer Research Center, Seattle, Washington

Reprints or correspondence: Dr. Michael Boeckh, Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. North, Box 258080, Seattle, WA 98109-4417 ([email protected]).

Journal of Infectious Diseases 180(2):p 572-574, August 1999. | DOI: 10.1086/314912
Copyright © Copyright Oxford University Press 1999.